Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
- PMID: 33382968
- PMCID: PMC7796900
- DOI: 10.1016/j.cell.2020.12.006
Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has claimed the lives of over one million people worldwide. The causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a member of the Coronaviridae family of viruses that can cause respiratory infections of varying severity. The cellular host factors and pathways co-opted during SARS-CoV-2 and related coronavirus life cycles remain ill defined. To address this gap, we performed genome-scale CRISPR knockout screens during infection by SARS-CoV-2 and three seasonal coronaviruses (HCoV-OC43, HCoV-NL63, and HCoV-229E). These screens uncovered host factors and pathways with pan-coronavirus and virus-specific functional roles, including major dependency on glycosaminoglycan biosynthesis, sterol regulatory element-binding protein (SREBP) signaling, bone morphogenetic protein (BMP) signaling, and glycosylphosphatidylinositol biosynthesis, as well as a requirement for several poorly characterized proteins. We identified an absolute requirement for the VMP1, TMEM41, and TMEM64 (VTT) domain-containing protein transmembrane protein 41B (TMEM41B) for infection by SARS-CoV-2 and three seasonal coronaviruses. This human coronavirus host factor compendium represents a rich resource to develop new therapeutic strategies for acute COVID-19 and potential future coronavirus pandemics.
Keywords: COVID-19; CRISPR; HCoV-229E; HCoV-NL63; HCoV-OC43; SARS-CoV-2; TMEM41B; coronavirus; genetic screens; host factors.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests S.W.L. is an advisor for and has equity in the following biotechnology companies: ORIC Pharmaceuticals, Faeth Therapeutics, Blueprint Medicines, Geras Bio, Mirimus Inc., PMV Pharmaceuticals, and Constellation Pharmaceuticals. C.M.R. is a founder of Apath LLC; a Scientific Advisory Board member of Imvaq Therapeutics; Vir Biotechnology, and Arbutus Biopharma; and an advisor for Regulus Therapeutics and Pfizer.
Figures











Update of
-
Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks.bioRxiv [Preprint]. 2020 Oct 8:2020.10.07.326462. doi: 10.1101/2020.10.07.326462. bioRxiv. 2020. Update in: Cell. 2021 Jan 7;184(1):120-132.e14. doi: 10.1016/j.cell.2020.12.006. PMID: 33052332 Free PMC article. Updated. Preprint.
References
-
- Aikawa J., Grobe K., Tsujimoto M., Esko J.D. Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase. Structure and activity of the fourth member, NDST4. J. Biol. Chem. 2001;276:5876–5882. - PubMed
-
- Baggen J., Persoons L., Jansen S., Vanstreels E., Jacquemyn M., Jochmans D., Neyts J., Dallmeier K., Maes P., Daelemans D. Identification of TMEM106B as proviral host factor for SARS-CoV-2. bioRxiv. 2020 doi: 10.1101/2020.09.28.316281. - DOI
-
- Bai X., Zhou D., Brown J.R., Crawford B.E., Hennet T., Esko J.D. Biosynthesis of the linkage region of glycosaminoglycans: cloning and activity of galactosyltransferase II, the sixth member of the beta 1,3-galactosyltransferase family (beta 3GalT6) J. Biol. Chem. 2001;276:48189–48195. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI150275/AI/NIAID NIH HHS/United States
- R01 AI116943/AI/NIAID NIH HHS/United States
- P30 CA016087/CA/NCI NIH HHS/United States
- R01 AI091707/AI/NIAID NIH HHS/United States
- U01 CA213359/CA/NCI NIH HHS/United States
- R01 CA190261/CA/NCI NIH HHS/United States
- R01 AI124690/AI/NIAID NIH HHS/United States
- F32 AI133910/AI/NIAID NIH HHS/United States
- P01 AI138938/AI/NIAID NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
- R01 CA213448/CA/NCI NIH HHS/United States
- U19 AI111825/AI/NIAID NIH HHS/United States
- R03 AI141855/AI/NIAID NIH HHS/United States
- T32 CA160001/CA/NCI NIH HHS/United States
- R21 AI161212/AI/NIAID NIH HHS/United States
- R01 AI143295/AI/NIAID NIH HHS/United States
- R21 AI142010/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous